BEDFORD, Mass.– Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences:
Jefferies Virtual Healthcare Conference
Date: Tuesday, June 1, 2021
Analyst-hosted fireside chat: 4:00 PM ET
The JMP Securities Life Sciences Conference
Date: Wednesday, June 16, 2021
Analyst-hosted fireside chat: 12:00 PM ET
Raymond James Healthcare Conference 2021
Date: Wednesday, June 23, 2021
New Treatments for Dry Eye Panel: 1:20 PM ET
Management will be available throughout the day for virtual investor meetings at all of the conferences. If you plan to attend at least one of the conferences and are interested in meeting with management, please contact your Jefferies, JMP Securities or Raymond James representative.
